BridgeMD
Tests treatment safety and results for Postherpetic Neuralgia
Official title Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.
ClinicalTrials.gov ID: NCT06290661
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate safety and efficacy of percutaneous peripheral nerve stimulation in patients with peripheral neuropathic pain. The main questions it aims to answer are: 1.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years old and above, male or female
- Diagnosed by trained clinical doctors as postherpetic neuralgia, which is an indication for peripheral nerve stimulation therapy;
- Assess the damage or disease of the peripheral sensory system through the four questions of Douleur Neuropathy before surgery;
- The subject has received conventional treatment but the how well it works is poor, or cannot tolerate the side effects of conventional treatment;
- Visual analogue scale for pain within 24 hours before surgery ≥ 5;
You likely can't join if
- people who need to receive both radio frequency modulation and intrathecal drug infusion treatment simultaneously;
- people who are known to have cardiac implants (pacemakers or defibrillators) or other implantable neural stimulators (spinal cord stimulators or deep...
- people with severe psychological and/or mental disorders and/or non therapeutic drug dependence;
- people expected to undergo MRI examination within 30 days after PNS implantation;
- Expected to be discharged within 48 hours or less;
- Target nerve damage or muscle defects in known pain areas;
See the full eligibility criteria
- 18 years old and above, male or female
- Diagnosed by trained clinical doctors as postherpetic neuralgia, which is an indication for peripheral nerve stimulation therapy;
- Assess the damage or disease of the peripheral sensory system through the four questions of Douleur Neuropathy before surgery;
- The subject has received conventional treatment but the how well it works is poor, or cannot tolerate the side effects of conventional treatment;
- Visual analogue scale for pain within 24 hours before surgery ≥ 5;
- The people are able to understand the purpose of this study, have sufficient compliance with the research treatment, and are willing to sign an informed consent form;
- people who need to receive both radio frequency modulation and intrathecal drug infusion treatment simultaneously;
- people who are known to have cardiac implants (pacemakers or defibrillators) or other implantable neural stimulators (spinal cord stimulators or deep brain stimulators, etc.);
- people with severe psychological and/or mental disorders and/or non therapeutic drug dependence;
- people expected to undergo MRI examination within 30 days after PNS implantation;
- Expected to be discharged within 48 hours or less;
- Target nerve damage or muscle defects in known pain areas;
- people who are known to be allergic to skin contact materials (tape or adhesive);
- Allergy to anesthetics such as lidocaine;
- Concomitant severe heart disease, liver disease, kidney disease, respiratory system disease, and coagulation dysfunction;
- Pregnant women, lactating women, or women planning to have children within the next three months;
- people who have participated in any other clinical trial, or who may participate in any other trial after enrollment;
- Other situations that the researcher deems unsuitable for participation in this clinical trial
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.